The UK Kawasaki Disease Foundation

Kawasaki Disease has many effects on a child and as such a multi-disciplinary approach to research/care is needed for this disease. Societi is supported by the phenomenal clinical expertise of:

Prof Robert Tulloh; MA DM FRCPCH Consultant in Paediatric Cardiology and Pulmonary Hypertension, Clinical Lead, Paediatric Cardiac Services, Bristol Royal Hospital for Children

Prof Paul Brogan; ​Professor of Vasculitis and Honorary Consultant Paediatric Rheumatologist, Great Ormond Street Hospital
Prof Michael Levin; Professor of Paediatrics & International Child Health, Imperial College London

Only by working and acting together can we overcome the immediate threat that Kawasaki Disease presents.

Kawasaki Disease is the leading cause of acquired heart disease in children in the UK.'s time we changed that.

Visit our Crowdfunding page to make a donation



Who We Are

We want to grow our                    partnership to tackle Kawasaki Disease


​                                            ...What can  you  bring?

Rachael McCormack, who has had direct experience of Kawasaki Disease, is the Founder of Societi.  Rachael is a management and leadership professional and drives forward the day-to-day business of our organisation, as a volunteer.

Scientific Advisory Board 

Our Board 

Our Board Members bring together a strong combination of skills and expertise:

Peter Andrews, MBA, Societi Chairman
Rachael McCormack, FCMI, FILM, Founder
Dr Vicki Clarke, General Practitioner
Roger Greenwood, FLI
Prof Robert Tulloh, MA DM FRCPCH Consultant in Paediatric Cardiology and Pulmonary Hypertension

Claire Thomson, Designer and Researcher

​Sue Davidson/Nicky Clements, KSSG UK (advisory members)

Whilst Kawasaki Disease presents a current and growing risk of scale to the UKs heart health, early intervention preventative measures are possibleand can be put in place cost effectively. Please help us make that difference.